MyFinsight
Home
About
Contact
Back
Income Statement
BridgeBio Pharma, Inc. (BBIO)
source: myfinsight.com
Download
Download image
Net loss
attributable to common...
-$181,903K
Net loss
attributable to redeemable...
-$1,855K
Net loss
-$183,758K
Loss before income
taxes
-$181,658K
Income tax expense
$2,100K
License And Services
Revenue
$37,440K
Net Product Revenue
$71,501K
Royalty Revenue
$1,624K
Total other income
(expense), net
-$47,380K
Loss from operations
-$134,278K
Interest income
$3,898K
Other income
(expense), net
$6,548K
Total revenues, net
$110,565K
Net loss from equity
method investments
-$20,189K
Interest expense
$37,637K
Total operating costs
and expenses
$244,843K
Total cost of revenues
$3,653K
Research and development
$111,231K
Restructuring, impairment and
related charges
$805K
Selling, general and
administrative
$129,154K
Cost Of Goods Sold
$2,848K
Cost Of License
Services And Royalty...
$805K
Back